Literature DB >> 15781144

Expression of human neuronal protein 22, a novel cytoskeleton-associated protein, was decreased in the anterior cingulate cortex of schizophrenia.

Masayuki Ito1, Iris Depaz, Peter Wilce, Toshimitsu Suzuki, Shin-ichi Niwa, Izuru Matsumoto.   

Abstract

Human neuronal protein 22 (hNP22) is a novel neuron-specific protein featuring numerous motifs previously described in cytoskeleton-associating and signaling proteins. Because previous studies have supported abnormalities in neuronal cytoarchitecture and/or development in the schizophrenia brain, we examined the expression of hNP22 in the anterior cingulate cortex, the hippocampus and the prefrontal cortex of schizophrenic and normal control postmortem brains using high-sensitive immunohistochemistry. Seven schizophrenic and seven age- and sex-matched control brains were examined. The ratio of hNP22-immunopositive cells/total cells was significantly reduced in layer V (p=.020) and layer VI (p=.022) of the anterior cingulate cortex of schizophrenic brain compared with controls. In contrast, there were no significant changes observed in the hippocampus and the prefrontal cortex. These results suggest that altered expression of hNP22 may be associated with modifications in neuronal cytoarchitecture leading to dysregulation of neural signal transduction in the anterior cingulate cortex of the schizophrenia brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781144     DOI: 10.1016/j.neulet.2004.12.079

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury.

Authors:  Andrew K Ottens; Liliana Bustamante; Erin C Golden; Changping Yao; Ronald L Hayes; Kevin K W Wang; Frank C Tortella; Jitendra R Dave
Journal:  J Neurotrauma       Date:  2010-10-09       Impact factor: 5.269

2.  Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study.

Authors:  Yasuto Kunii; Keiko Ikemoto; Akira Wada; Qiaohui Yang; Takashi Kusakabe; Toshimitsu Suzuki; Shin-Ichi Niwa
Journal:  Med Mol Morphol       Date:  2011-12-17       Impact factor: 2.309

3.  The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.

Authors:  H Yoshino; T Chiyomaru; H Enokida; K Kawakami; S Tatarano; K Nishiyama; N Nohata; N Seki; M Nakagawa
Journal:  Br J Cancer       Date:  2011-02-08       Impact factor: 7.640

4.  Novel subtractive transcription-based amplification of mRNA (STAR) method and its application in search of rare and differentially expressed genes in AD brains.

Authors:  Qing Yan Liu; Roy R Sooknanan; Lawrence T Malek; Maria Ribecco-Lutkiewicz; Joy X Lei; Hui Shen; Boleslaw Lach; P Roy Walker; Joel Martin; Marianna Sikorska
Journal:  BMC Genomics       Date:  2006-11-07       Impact factor: 3.969

5.  Epigenetic signature of preterm birth in adult twins.

Authors:  Qihua Tan; Shuxia Li; Morten Frost; Marianne Nygaard; Mette Soerensen; Martin Larsen; Kaare Christensen; Lene Christiansen
Journal:  Clin Epigenetics       Date:  2018-06-27       Impact factor: 6.551

Review 6.  The importance of brain banks for molecular neuropathological research: The New South Wales Tissue Resource Centre experience.

Authors:  Irina Dedova; Antony Harding; Donna Sheedy; Therese Garrick; Nina Sundqvist; Clare Hunt; Juliette Gillies; Clive G Harper
Journal:  Int J Mol Sci       Date:  2009-01-23       Impact factor: 6.208

7.  Genomic Insights Into the Population History and Biological Adaptation of Southwestern Chinese Hmong-Mien People.

Authors:  Yan Liu; Jie Xie; Mengge Wang; Changhui Liu; Jingrong Zhu; Xing Zou; Wenshan Li; Lin Wang; Cuo Leng; Quyi Xu; Hui-Yuan Yeh; Chuan-Chao Wang; Xiaohong Wen; Chao Liu; Guanglin He
Journal:  Front Genet       Date:  2022-01-03       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.